IL-17 modulator 1 (disodium) is an orally active, highly efficacious IL-17 modulator extracted from patent WO 2020127685. IL-17 modulator 1 (disodium) can be used for the research of diseases including psoriasis, ankylosing spondylitis and psoriatic arthritis.
性状
Solid
IC50 & Target[1][2]
IL-17
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. WO 2020127685
溶解度数据
In Vitro: DMSO : 20 mg/mL (31.82 mM; ultrasonic and warming and heat to 80°C)配制储备液